Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Witkin

Showing results (201-210 of 321) with videos related to

Pageof 33
Sort By:
European Journal of Pharmacology|February 1, 2025
Safety, tolerability and pharmacokinetic profile of the low-impact ampakine CX717 in young healthy male subjects and elderly healthy male and female subjectsDaniel P Radin, Rok Cerne, Jodi L Smith, et al.
Biochemical Pharmacology|May 3, 2022
Can GABAkines quiet the noise? The GABA<sub>A</sub> receptor neurobiology and pharmacology of tinnitusJeffrey M Witkin, Arnold Lippa, Jodi L Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeonsJ M Witkin, J B Acri, G Wong, et al.
Neuroscience|March 1, 1997
Localization and pharmacological characterization of pigeon diazepam-insensitive GABAA receptorsJ B Acri, G Wong, T Lyon, et al.
Journal of Medicinal Chemistry|October 13, 1995
(+/-)-(N-alkylamino)benzazepine analogs: novel dopamine D1 receptor antagonistsJ H Shah, S Izenwasser, B Geter-Douglass, et al.
Trends in Pharmacological Sciences|November 2, 2005
A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disordersJeffrey M Witkin, Eleni T Tzavara, Richard J Davis, et al.
Future Medicinal Chemistry|September 20, 2024
Preclinical characterization of a water-soluble low-impact ampakine prodrug, CX1942 and its active moiety, CX1763Daniel P Radin, Sheng Zhong, Rok Cerne, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997
Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonistsB Geter-Douglass, J L Katz, K Alling, et al.
Surgical Neurology|April 1, 1993
Fertility following excision of a symptomatic craniopharyngioma during pregnancy: case reportR J Johnson, R M Voorhies, M Witkin, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1986
Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanismsJ E Barrett, J M Witkin, R S Mansbach, et al.
Pageof 33

Showing results (201-210 of 321) with videos related to

Sort By:
Pageof 33
European Journal of Pharmacology|February 1, 2025
Safety, tolerability and pharmacokinetic profile of the low-impact ampakine CX717 in young healthy male subjects and elderly healthy male and female subjectsDaniel P Radin, Rok Cerne, Jodi L Smith, et al.
Biochemical Pharmacology|May 3, 2022
Can GABAkines quiet the noise? The GABA<sub>A</sub> receptor neurobiology and pharmacology of tinnitusJeffrey M Witkin, Arnold Lippa, Jodi L Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeonsJ M Witkin, J B Acri, G Wong, et al.
Neuroscience|March 1, 1997
Localization and pharmacological characterization of pigeon diazepam-insensitive GABAA receptorsJ B Acri, G Wong, T Lyon, et al.
Journal of Medicinal Chemistry|October 13, 1995
(+/-)-(N-alkylamino)benzazepine analogs: novel dopamine D1 receptor antagonistsJ H Shah, S Izenwasser, B Geter-Douglass, et al.
Trends in Pharmacological Sciences|November 2, 2005
A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disordersJeffrey M Witkin, Eleni T Tzavara, Richard J Davis, et al.
Future Medicinal Chemistry|September 20, 2024
Preclinical characterization of a water-soluble low-impact ampakine prodrug, CX1942 and its active moiety, CX1763Daniel P Radin, Sheng Zhong, Rok Cerne, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997
Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonistsB Geter-Douglass, J L Katz, K Alling, et al.
Surgical Neurology|April 1, 1993
Fertility following excision of a symptomatic craniopharyngioma during pregnancy: case reportR J Johnson, R M Voorhies, M Witkin, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1986
Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanismsJ E Barrett, J M Witkin, R S Mansbach, et al.
Pageof 33